Breakthrough therapies, breakthrough economics in the era of curePublished: September 4, 2019
Market & Patient Access
Stephanie Farnia, Lisa Mostovoy, Carole Redding Flamm & Naomi Aronson
Cellular immunotherapies and gene replacement therapies herald new therapeutic categories and renewed discussion of how transformative therapies should be integrated into the US healthcare system. All stakeholders will need to participate in processes focused on long-term healthcare system stewardship.DOI: 10.18609/cgti.2019.086
Citation: Cell & Gene Therapy Insights 2019; 5(8), 931-936.